Tyche Industries Limited (BOM:532384)
India · Delayed Price · Currency is INR 112.40
-0.40 (-0.35%)
At close: Jan 23, 2026
Tyche Industries Revenue
Tyche Industries had revenue of 141.60M INR in the quarter ending September 30, 2025, a decrease of -31.05%. This brings the company's revenue in the last twelve months to 570.25M, down -21.51% year-over-year. In the fiscal year ending March 31, 2025, Tyche Industries had annual revenue of 662.22M, down -4.97%.
Revenue (ttm)
570.25M
Revenue Growth
-21.51%
P/S Ratio
2.03
Revenue / Employee
3.52M
Employees
162
Market Cap
1.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 662.22M | -34.63M | -4.97% |
| Mar 31, 2024 | 696.84M | -59.16M | -7.83% |
| Mar 31, 2023 | 756.00M | 125.84M | 19.97% |
| Mar 31, 2022 | 630.16M | -163.86M | -20.64% |
| Mar 31, 2021 | 794.02M | 51.29M | 6.91% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Smruthi Organics | 1.20B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Vasundhara Rasayans | 329.60M |